SHA:688189 Revenue

In the year 2025, Hunan Nucien Pharmaceutical had annual revenue of 141.93M CNY, down -46.09%. Hunan Nucien Pharmaceutical had revenue of 58.77M in the quarter ending December 31, 2025, with 382.77% growth.

Revenue

141.93M

Revenue Growth

-46.09%

P/S Ratio

15.79

Revenue / Employee

387.78K

Employees

319

Market Cap

2.24B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	141.93M	-121.36M	-46.09%
Dec 31, 2024	263.28M	-456.78M	-63.44%
Dec 31, 2023	720.06M	21.24M	3.04%
Dec 31, 2022	698.83M	-44.83M	-6.03%
Dec 31, 2021	743.66M	-285.48M	-27.74%
Dec 31, 2020	Pro	Pro	Pro
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro
Dec 31, 2017	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Jiangsu Gdk Biological Technology	113.23M
Hubei Goto Biopharm	626.28M
Guiyang Xintian Pharmaceutical	755.34M
Sailong Pharmaceutical Group	244.84M
Jiangsu CoWin Biotech	193.05M
Zhejiang East Asia Pharmaceutical	831.56M
Shanghai Serum Bio-Technology	196.21M
Shandong Sito Bio-technology	954.76M

Revenue Rankings